When loaded into two distinct polymeric platforms — a poly(vinyl alcohol)/sodium alginate/carboxymethylcellulose film and an acrylate copolymer hydrogel incorporating mesenchymal stem cell (MSC) secretome — resveratrol demonstrated progressive, consistent sustained release, while curcumin not only released poorly across both systems but actively compromised polymer matrix integrity and reduced resveratrol's release efficiency. The culprit is curcumin's notoriously low aqueous solubility, a pharmacokinetic liability well-documented in oral delivery research but underexplored in topical wound-dressing contexts.
This finding matters because chronic wound management remains a billion-dollar unmet clinical need, with sustained local delivery of anti-inflammatory and antioxidant compounds representing a rational therapeutic approach. The MSC secretome component is particularly novel — combining a biological signaling cocktail with small-molecule polyphenols is an emerging strategy, and confirming that the secretome-hydrogel scaffold can support resveratrol release without interference is a meaningful step forward. However, the limitations here are significant: purely in vitro release profiling using UV-Vis spectrophotometry tells us little about tissue penetration, cellular uptake, or wound-bed pharmacodynamics. No biological efficacy endpoints were tested. The curcumin failure underscores what decades of formulation science already know — this compound demands nanoencapsulation (liposomes, nanoparticles, cyclodextrin complexes) before any delivery platform can be considered viable. Incremental but practically instructive work for formulators.